Hauck & Aufhäuser Initiates Coverage of Medios AG with Buy Recommendation and €23.00 Price Target

Berlin, June 7, 2024 — Hauck & Aufhäuser Investment Banking has started coverage of Medios AG, recommending the shares as a “buy” with a price target of €23.00. This target is approximately 55 percent above the Xetra closing price of €14.86 on June 5, 2024. The coverage adds to that already provided by Berenberg, Bryan, Garnier & Co, Deutsche Bank, Jefferies, Kepler Cheuvreux, Metzler Capital Markets, and Warburg.

Medios AG, a leading Specialty Pharma provider in Europe, operates in Germany, the Netherlands, Belgium, and Spain. The company collaborates with key supply chain partners to offer innovative solutions and intelligent services. It focuses on pioneering individualized medicine to make advanced therapies accessible to everyone, alongside pharmacies, specialist practices, and pharmaceutical companies.

The shares of Medios AG, Germany's first listed specialty pharmaceutical company, are traded on the Regulated Market of the Frankfurt Stock Exchange (Prime Standard).